BeOne Medicines - About the company
BeOne Medicines is an unfunded company based in Cambridge (United States), founded in 2010. It operates as a Provider of innovative oncology treatments and solutions through a science-driven approach to addressing cancer care globally. BeOne Medicines has not raised any funding yet. The company has 3423 active competitors, including 1128 funded and 788 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Kite Pharma.
Company Details
Provider of innovative oncology treatments and solutions through a science-driven approach to addressing cancer care globally. It is a company that specializes in discovering and developing innovative treatments for cancer patients worldwide, driven by a science-led and purpose-driven model to improve treatment access.
- Website
- beonemedicines.com
- Social
- Phone Number
- +91 **********
Key Metrics
Founded Year
2010
Location
Cambridge, United States
Stage
Unfunded
Ranked
997th among 3423 active competitors
Employee Count
3,805 as on Sep 30, 2026
Similar Companies
Sign up to download BeOne Medicines' company profile
BeOne Medicines's funding and investors
BeOne Medicines has not raised any funding rounds yet.
BeOne Medicines' founders and board of directors
Founder? Claim ProfileBeOne Medicines' employee count trend
BeOne Medicines has 3,805 employees as of Sep 26. Here is BeOne Medicines's employee count trend over the years:
Uncover BeOne Medicines' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BeOne Medicines's Competitors and alternates
Top competitors of BeOne Medicines include Jazz Pharmaceuticals, BeiGene and Kite Pharma. Here is the list of Top 10 competitors of BeOne Medicines, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 77/100 | |
3rd | Kite Pharma 2009, Los Angeles (United States), Acquired | Developer of cancer immunotherapy products using genetic engineering | $97.7M | 76/100 | |
4th |  Attovia 2023, Fremont (United States), Public | Developer of antibody-based therapeutics for immune-mediated diseases and oncology | $255M | 72/100 | |
5th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 72/100 | |
6th |  Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
7th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
8th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 71/100 | ||
9th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
10th |  Strand Therapeutics 2017, Cambridge (United States), Series B | Provider of platform to deliver mRNA therapeutics for multi functional treatments | $256M | 71/100 | |
997th | BeOne Medicines 2010, Cambridge (United States), Unfunded | Provider of innovative oncology treatments and solutions through a science-driven approach to addressing cancer care globally | - | - | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on BeOne Medicines's competitors? Click here to see the top ones
BeOne Medicines's Investments and acquisitions
BeOne Medicines has made no investments or acquisitions yet.
Reports related to BeOne Medicines
Here is the latest report on BeOne Medicines's sector:
News related to BeOne Medicines
Filter this listMedia has covered BeOne Medicines for a total of 71 events in the last 1 year, 38 of them have been about company updates and 6 about partnerships.
•
BeOne Medicines' BRUKINSA Combination Receives Priority Review for First-Line Mantle Cell Lymphoma TreatmentNewswire•Nov 06, 2026•BeOne Medicines
•
BeOne Medicines Announces Third Quarter 2026 Financial Results and Business UpdatesBusiness Wire•Nov 05, 2026•BeOne Medicines
•
BeOne Medicines announces compelling data for refractory liver and lung cancer at ESMO 2026Business Wire•Oct 26, 2026•BeOne Medicines
•
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combo in First-Line HER2+ Gastroesophageal CancerFinancial Post•Oct 23, 2026•BeOne Medicines
•
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026Newswire•Oct 20, 2026•BeOne Medicines
•
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Patient Access to Cancer Medicines and Strengthen U.SMedia Bulletins•Sep 01, 2026•BeOne Medicines, USAGov
•
•
Hims Enters Australia, Marking First Expansion into the Asia-Pacific MarketBusiness Wire•Sep 01, 2026•BeOne Medicines
•
BeOne Medicines' U.S. drug manufacturing investment tops $1 billionStocktitan•Aug 31, 2026•BeOne Medicines
•
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal CancerFinancial Post•Aug 31, 2026•BeOne Medicines
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about BeOne Medicines
Explore our recently published companies
- Social with Opal - Unfunded company
- UnityGrid AI - Washington, DC based, 2024 founded, Unfunded company
- Sentient Grid - Mumbai based, 2025 founded, Funding Raised company
- Adopt Nettech - Delhi based, 2020 founded, Unfunded company
- HGS - Bengaluru based, 1973 founded, Unfunded company
- Honeyanddough - India based, Unfunded company
